The development of rapid and low-cost cell therapy products represents a significant advancement in the field of cell therapy. Compared to the conventional CAR-T cell manufacturing process which takes up to 14 days, the rapid, so called “GoFast” process eliminates the expansion step and completes within 72 hours. This process minimizes cell differentiation and exhaustion, thus produces cells with higher potency and higher anti-tumor activity.
Poster presented at ASGCT2025.
